Results 201 to 210 of about 84,866 (261)

Off‐Label Initiation of Gabapentin and Valproic Acid Among Long‐Stay Nursing Home Residents With and Without Dementia

open access: yes
Journal of the American Geriatrics Society, EarlyView.
Lauren B. Gerlach   +6 more
wiley   +1 more source

Dextromethorphan Hydrobromide‐Bupropion Hydrochloride for Agitation in Dementia: Combination or Two Stand‐Alone Drugs

open access: yes
Journal of the American Geriatrics Society, EarlyView.
Eric E. Brown   +2 more
wiley   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Antipsychotics

Clinics in Geriatric Medicine, 1990
The multiple medical problems in the geriatric population complicate the issues of diagnosis and management of behavioral symptoms. Systematic evaluation of the etiology, course, and prognosis of behavioral and psychotic symptoms associated with dementia may clarify the indications for treatment.
M, Phillipson   +3 more
openaire   +2 more sources

How Antipsychotic Are the Antipsychotics?: A Clinical Study of the Subjective Antipsychotic Effect of the Antipsychotics in Chronic Schizophrenia

Annals of Clinical Psychiatry, 1989
AbstractA systematic study of 39 chronic schizophrenic outpatients receiving antipsychotics at the Iowa City Veterans Administration Hospital was performed to determine the extent of the subjective antipsychotic response to antipsychotic medications. While on therapeutic dosages of antipsychotic medications, no delusions or hallucinations were reported
James Chandler, George Winokur
openaire   +1 more source

Antipsychotics in pregnancy

Journal of Psychiatric and Mental Health Nursing, 2010
Women who are pregnant and who have a history of psychosis are commonly managed with antipsychotic medications. The evidence regarding the use of antipsychotics in pregnancy has been insufficient to provide adequate support for this practice and is a concern for clinicians and women alike.
K, McCauley-Elsom   +3 more
openaire   +2 more sources

Antipsychotics as antidepressants

Asia-Pacific Psychiatry, 2015
AbstractThree second‐generation antipsychotic (SGA) agents have receivedFDAapproval for adjunctive treatment, to antidepressant, of major depressive disorder: quetiapine, aripiprazole, and olanzapine. Additionally, quetiapine and lurasidone have been approved for the treatment of bipolar depression.
Rona Jeannie, Roberts   +2 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy